Compare OBIO & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OBIO | ELMD |
|---|---|---|
| Founded | 2017 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.7M | 208.1M |
| IPO Year | 2020 | 2010 |
| Metric | OBIO | ELMD |
|---|---|---|
| Price | $3.92 | $45.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $14.25 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 535.0K | 75.6K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.13 | ★ 46.55 |
| EPS | N/A | ★ 0.91 |
| Revenue | $33,482,000.00 | ★ $54,716,000.00 |
| Revenue This Year | N/A | $15.59 |
| Revenue Next Year | $12.43 | $11.51 |
| P/E Ratio | ★ N/A | $48.29 |
| Revenue Growth | ★ 1169.22 | 13.83 |
| 52 Week Low | $2.20 | $17.73 |
| 52 Week High | $5.42 | $47.40 |
| Indicator | OBIO | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 72.30 |
| Support Level | $3.47 | $23.51 |
| Resistance Level | $4.18 | N/A |
| Average True Range (ATR) | 0.28 | 1.95 |
| MACD | -0.03 | 0.33 |
| Stochastic Oscillator | 12.53 | 88.04 |
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.